Scientific Zambon Pharma April 10, 2017 ZAMBON LAUNCHES XADAGO® (SAFINAMIDE) IN PORTUGAL FOR PATIENTS WITH MID- TO LATE-STAGE PARKINSON’S DISEASE
Scientific Zambon Pharma March 21, 2017 FDA APPROVES XADAGO® (SAFINAMIDE) FOR PARKINSON’S DISEASE (PD) PATIENTS
Institutional Zambon Pharma January 10, 2017 Seqirus and Zambon enter into a partnership for Parkinson’s disease product in Australia and New Zealand
Institutional Zambon Pharma November 2, 2016 Agreement Zambon - Fabbrica Italiana Sintetici (FIS) for the development of the Lonigo plant
Scientific Zambon Pharma September 1, 2016 Zambon launches Xadago® (safinamide) in Norway for patients with mid- to late-stage Parkinson's disease
